A detailed history of Clark Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clark Asset Management, LLC holds 662 shares of LLY stock, worth $555,993. This represents 0.07% of its overall portfolio holdings.

Number of Shares
662
Previous 616 7.47%
Holding current value
$555,993
Previous $509 Million 1.43%
% of portfolio
0.07%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

BUY
$713.71 - $898.95 $32,830 - $41,351
46 Added 7.47%
662 $516 Million
Q1 2025

Apr 28, 2025

BUY
$725.72 - $929.72 $116,115 - $148,755
160 Added 35.09%
616 $509 Million
Q4 2024

Apr 02, 2025

BUY
$727.2 - $932.06 $331,603 - $425,019
456 New
456 $352 Million
Q3 2024

Apr 28, 2025

BUY
$772.14 - $960.02 $142,845 - $177,603
185 Added 39.7%
651 $577 Million
Q2 2024

Apr 28, 2025

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 2.19%
466 $422 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $798B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clark Asset Management, LLC Portfolio

Follow Clark Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clark Asset Management, LLC with notifications on news.